novo nordisk oral glp-1 Nordisk's weight loss pill approved by FDA Novo Nordisk stock soars after

Although these mechanisms have been exploited to facilitate weight loss, these medications have also been indicated for patients with cardiovascular or renal diseases, all of which have caused a recent drastic rise in prescribing GLP-1 RAs

For a long time, it was considered a decent estimation for whether people were at a healthy weight

There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)

This builds on what we already know: menopause fundamentally alters metabolism

Learn how GLP-1 meds affect fertility, birth control, and abortion optionsplus what to do if you get pregnant.

KIDNEY FUNCTION